New projects approved for funding: Sleep apnea and admin relief
Two new projects have been approved by Biovia (formerly flanders.bio/MEDVIA) and VLAIO to receive funding: IMSAD and CareAIgent. Both of these innovative projects bring a fresh and forward-thinking approach to healthcare challenges, demonstrating the strength of collaborative innovation within our ecosystem.
Over the years we’ve helped 27 projects involving more than 70 companies, hospitals and research institutes gain VLAIO funding worth a total of over €16 million. Biovia actively supports applicants through every step of the process, from ideation and consortium building to application guidance and final submission.
We’ve recently opened our latest project Call 2025.2 and have an information webinar scheduled for 26 August. So if you have an innovative idea of your own, now is the time to get moving!
Biovia has helped 27 innovative health projects gain VLAIO funding worth over €16 million
Two new projects approved
IMSAD
Consortium: LTSM Systems / UZA / Voxdale
Grant: €173,155
The IMSAD project focuses on developing and clinically validating a next-generation sleep apnea monitor that enables accurate level three sleep studies to be performed at home. Led by LTSM Systems in collaboration with Voxdale and the University Hospital of Antwerp (UZA), the project aims to eliminate common issues like sensor misplacement and cable disconnection while capturing key medical data such as airflow, SpO₂, respiratory effort and heart rate. By combining expertise in medtech design, flexible electronics and clinical sleep diagnostics, IMSAD supports more accessible, patient-friendly sleep monitoring and contributes to innovation in home-based medical diagnostics.
CareAIgent
Recipient: Hogeschool PXL
Grant: €431,517
The CareAIgent project aims to relieve caregivers of time-consuming administrative tasks by helping to implement AI technologies – such as Large Language Models (LLMs) – in the healthcare sector. The project provides practical solutions, such as an implementation framework specifically tailored to the needs of the care sector, to lower both technical and organizational barriers. For tech companies, the project offers a unique opportunity to validate and adapt existing AI solutions. CareAIgent disseminates specialized market knowledge for AI products, increases their visibility in healthcare and offers both the healthcare and IT sectors opportunities for knowledge exchange and co-creation.
Call 2025.2 is now open
We encourage healthtech, biotech and digital health companies with an innovative idea for a collaborative project to apply for VLAIO funding through Biovia’s newly opened 2025.2 call. Whether you’re developing a new medical device, data platform, digital solution, therapeutic or diagnostic, this call offers a valuable opportunity to help bring your ideas to life.
Not sure where to start? Biovia can help. We provide one-on-one support to help shape your project idea, find the right partners and guide you through the entire application process.
Join the Info Webinar on 26 August 2025
Get inspired, get informed and get ready to apply: On 26 August, Biovia is organizing a free info webinar to walk you through the 2025.2 call process. You’ll learn about eligibility, timelines and evaluation criteria, as well as get practical tips for crafting a successful proposal. Whether you’ve got a fully fleshed out proposal or just the beginnings of an idea, our innovation experts will help guide you in the right direction with time for questions.
Contact our innovation team
Want to explore a project idea or learn more about the call? Reach out to our Innovation Team at innovation@biovia.be.
Biovia helps you turn your idea into reality with €8 million in non-dilutive VLAIO funding earmarked annually for collaborative projects. Get in touch, and let’s build the future of health innovation together!
If you miss the 2025.2 Call, you can always apply for the next one! Sign up to the Biovia newsletter to stay up to date, use our RFP tool or get in touch!